Background: Carcinoid tumours are neuroendocrine neoplasms mainly located in the gastrointestinal tract and bronchopulmonary system. Our study's aim was to characterise the familial nature of gastrointestinal carcinoid tumours using the Swedish Family-Cancer Database, which includes >11.5 million individuals.
introduction
Carcinoid tumours are slow-growing neuroendocrine neoplasms that produce vasoactive substances, most notably serotonin [1] . According to the largest current epidemiological study on carcinoids, the gastrointestinal tract accounts for 67.5% of all carcinoid tumours [2] . In Sweden, the small intestine and the appendix are the most common sites for carcinoid tumours [3] . Carcinoid tumours comprise >40% of all small intestinal primary tumours [2, 4] . Appendiceal carcinoids are the most frequent malignant tumours of the gastrointestinal tract in children. [5] . According to a Swedish autopsy study, the prevalence of carcinoid tumours is 8/100 000 [6] . The incidence rate for carcinoids has been estimated at 1-4 per 100 000 person-years [3, [7] [8] [9] [10] [11] [12] .
Frequently, carcinoid tumours are only diagnosed after their metastatic spread or the onset of the carcinoid syndrome-the result of the excessive levels of vasoactive substances produced by the carcinoid tissue [13, 14] . The prognosis of metastasised colorectal carcinoids is as poor as those of adenocarcinomas [15] . Most carcinoids are sporadic but epidemiological studies report a familial risk [16, 17] . Moreover, carcinoids can occur within the multiple endocrine neoplasia (MEN) syndrome, a rare familiar tumour syndrome in which mutations in the MEN1 gene are manifested [18] .
Studying the familial clustering of carcinoid tumours with other malignancies gives clues to the aetiology of the disease. The Swedish Family-Cancer Database has been used previously to assess familial risks and incidence trends of carcinoid tumours from 1958 to 1998 [3, 16] . The Database was updated in 2006 and now includes >1.2 million tumours diagnosed between 1958 and 2004, thus representing an increase of 30% in the number of familial cases [19] which permitted us to explore the association of location-specific gastrointestinal carcinoids with site-specific invasive cancers. An important advantage of the Database is that information on familial relationships and cancers comes from registered sources of complete coverage, thus offering unique possibilities for precise and unbiased assessment [20] .
methods and subjects
The population-based Swedish Family-Cancer Database was created by linking the Multigeneration Register at Statistics Sweden to the Swedish Cancer Registry [20] Relative risks (RRs) with 95% confidence intervals (CIs) were used to compare the incidence of cancer among those whose family was affected by cancer with the incidence of cancer among those who did not have a family history of cancer. Cases of cancer and person-years were classified according to the gender family history of cancer calendar year and age. The distribution of the number of cases in each group was modelled by Poisson regression. The Genmod procedure of the SAS software was used for the analysis (SAS Version 9.1; SAS Institute, Cary, NC). Standard Poisson regression assumes independent observations. In order to account for the possible overdispersion of the data due to clustered family structure, standard errors were adjusted using Pearsons' chi-square divided by the degrees of freedom. The adjustment resulted in slightly wider CIs. For example, the RR of carcinoid tumours in individuals with a parental history was 4.33 (95% CI 2.46-7.62) after adjustment. Since this procedure may be particularly sensitive to outlying observations that are expected in our large dataset, we show in this article unadjusted CIs and point out to the possibility of conservative confidence limits due to familial dependence. Results in Tables 1 and 2 are only presented for sites with at least 10 carcinoid patients with a family history of cancer.
results
The offspring generation of the Database includes 2424 individuals diagnosed with carcinoid tumours. Among them, 23 patients had a parental history of carcinoid tumours. Carcinoids in patients with a parental history were located in the small intestine (11 cases), colorectum (eight cases) and the lung (two cases); two carcinoids had unknown locations. The risk of carcinoid tumours was significantly higher among individuals with a parental history of carcinoid tumours (RR 4.33) and in individuals with a sibling history of carcinoid tumours (RR 2.88; Table 1 ). Parental carcinoids were associated with small intestinal (RR 11.80) and colon carcinoids (RR 2.78) in the offspring.
The risk of carcinoid tumour was increased among the offspring of patients with cancers of the liver (RR 1.78), breast (RR 1.27), urinary organs (RR 1.59) and the brain (RR 1.47, Table 2 ). Offspring carcinoid tumours were associated with parental history of non-Hodgkin's lymphoma (RR 1.49). The risk of appendiceal carcinoid tumour was increased among the offspring of patients with cancer of the breast (RR 1.43) and urinary organs (RR 2.14). There was an increased risk of small intestinal carcinoid tumour among the offspring of patients with squamous cell skin cancer (RR 1.79) and non-Hodgkin's lymphoma (RR 2.06). The risk of carcinoid tumour of the small intestine was increased among individuals whose mother had endometrial cancer (RR 2.21). The risk of carcinoid tumour was elevated among those whose siblings were affected by colon (RR 1.93), rectum (RR 1.89), brain (RR 1.65) and cervical cancers (RR 1.96).
Parental carcinoids at any site were associated in the offspring with an increased risk of melanoma (RR 1.50) ( Table 3 ). There was an elevated risk of thyroid (RR 2.14) and endocrine gland cancers (RR 1.64) among those whose parent was diagnosed with carcinoid tumour. The offspring of patients diagnosed with small intestinal carcinoids had an increased risk of cancer of the breast (RR 1.39), kidney (RR 2.08) and brain (RR 1.65). The risk of leukaemia was increased among those whose parent had appendiceal carcinoids (RR 2.79). Of the six parents affected with appendiceal carcinoid, one had a child diagnosed with leukaemia at the age of 4; another parent had a child diagnosed with leukaemia at the age of 7. The RR of adult leukaemia among those with parental stomach carcinoid tumours was 2.97, but the risk was not significant at the 5% level (95% CI 0.96-9.21).
discussion
In the past, carcinoid tumours were considered to be sporadic. However, familial clustering of carcinoid tumours has been described in both case reports and epidemiological studies [3, 16, 17, 24, 25] . Familial aggregation of cancer can be due to shared genetic background or common environmental exposures within families. In agreement with previous studies, 
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our results indicate that individuals with a parental history of carcinoids have an increased (more than four times higher) probability of developing carcinoids [16, 17] . Carcinoid tumours found in families affected by the MEN1 syndrome are mostly located in the thymus, bronchus and stomach, and familiar carcinoids not associated with MEN1 have been also described [25] [26] [27] . In our study, among the 23 familial carcinoids, two tumours in the offspring generation were located in the lung; one parental carcinoid was located in the lung and another one in the stomach (results not shown). Thus, the contribution of the MEN1 syndrome to the familial clustering of carcinoid tumours observed in the present study seems to be small. Literature on possible association between family history of cancer and risk of carcinoid tumours is sparse [16, 17] . One study did not find increased risks of malignant tumours among patients with carcinoids or among their first-degree relatives [17] . In contrast, the present associations between carcinoid tumours and invasive cancers of the endocrine glands and the urinary organs have been described before [16] . Our population-based study suggests additional associations between carcinoids and invasive cancers. The offspring of patients diagnosed with cancer of the brain and kidney were at an increased risk of small intestinal carcinoid tumour. The identified association from the reverse analysis-the offspring of individuals diagnosed with small intestinal carcinoid tumours had an increased risk of kidney and brain cancers-adds consistency to our data. Moreover, some of the present associations are consistent with second primary cancer studies. Women have been found to be at an increased risk of colon, small intestine and thyroid gland cancers after carcinoids [16] . The involved types among men have been colon, small intestine, prostate and skin cancers and non-Hodgkin's lymphoma [16] . There was an increased risk of melanoma after small intestinal carcinoid [28] .
A potential limitation of our study was the unavailability of information on hypothetical risk factors such as tobacco smoking, alcohol consumption and diet. It is important to note that some of the significant associations could be attributed to the play of chance as well. Since carcinoid tumours are uncommon, some of the observed increased risks were based on a small number of cases. The problem could be alleviated when future updates of the Database or independent studies are available.
The results of the present study show that first-degree relatives of patients with carcinoid cancer are at an increased risk of developing the disease. Carcinoid tumours are rare and screening by full body computed tomography scanning and/or panendoscopy, even in high-risk groups (e.g. smokers with a family history), is probably not justified. This study also confirms the familial aggregation of carcinoid tumours with other noncarcinoid malignancies. According to our results, a parental history of small intestinal carcinoid tumours is a risk factor for brain, kidney and breast cancers. The translation of these data into screening programmes (e.g. should women with a family history of carcinoid tumours start with mammographies at younger ages?) needs further research. However, the relatively high familial risks should stimulate efforts for gene identification.
The present population-based study investigated the familial aggregation of carcinoid tumours with other noncarcinoid neoplasms in the Swedish population. An advantage of our study related to the attained sample size was the possibility to investigate the familial clustering of carcinoids according to their location. In summary, our data provide population-based evidence that family history of carcinoid tumours is a risk factor for carcinoid tumours. Parental history of invasive cancer of the brain, endocrine glands and urinary organs was associated with carcinoid tumours in the offspring. An association was also found between carcinoid tumours in the offspring and parental non-Hodgkin's lymphoma. In addition, parental invasive cancers of the kidney as well as squamous cell references
